Moss, D.E., Braglia, E., and Pericle, F. Methanesulfonyl fluoride (SNX-001): A unique irreversible AChE inhibitor for the treatment of dementia. Keystone Symposia: Alzheimer’s Disease Beyond ABeta (A4), Copper Mountain Resort, Copper Mountain, CO, January 10-15, 2010.
Borlongan, C.V., Sumaya, I., and Moss, D.E. (2002). Pineal gland: A novel tissue source for neural transplantation therapy in stroke. Presented to the 32nd Annual Meeting of the Society for Neuroscience, November 2-7, 2002, Orlando, FL. Society for Neuroscience Abstracts, 28, #34.11.
Byers, D.M., Moss, D.E., Irwin, L.N. (2002). Global patterns and functional analysis of gene expression in Alzheimer's disease. Presented to the 32nd Annual Meeting of the Society for Neuroscience, November 2-7, 2002, Orlando, FL. Society for Neuroscience Abstracts, 28, #590.15.
Sumaya, I.C., Byers, D., Moss, D.E., and Irwin, L. (2002). Effect of melatonin on striatial gene expression in an animal model of parkinsonism in both the light and the dark phases. Presented to the XXXIV Congress of the International Union of Physiological Sciences, August 21-23, 2002, Adelaide, Australia. Congress of the International Union of Physiological Sciences Abstracts, 012.
Borlongan, C.V., Sumaya, I., Moss, D.E., Kumazaki, M., Sakurai, T., Hida, H., and Nishino, H. (2002). Intracerebral transplantation of melatonin-secreting pineal gland protects against stroke-induced deficits in rats. Presented to the 8th International Neural Transplantation and Repair Conference, Keystone, Colorado, June 12-16, 2002.